Abstract
Purpose: To identify the predictors for anatomical and functional outcome after re-vitrectomy with application of autologous platelet concentrate (APC) in eyes with persistent idiopathic macular hole (MH). Methods: Retrospective study of 103 eyes with persistent MHs after vitrectomy with peeling of internal limiting membrane (ILM) and expansive gas. All patients underwent re-vitrectomy with APC and endotamponade. The anatomical MH closure rate and postoperative best-corrected visual acuity (BCVA) were evaluated. Further, predictive factors influencing the success of the surgery were analyzed. Results: Median BCVA (logMAR) before the surgery was 1.00 (interquartile range [IQR] 0.80–1.30) and the median of minimum diameter between hole edges was 508 µm (IQR 387–631). The final closure rate after re-vitrectomy with APC was 60.2% (62 of 103 eyes). The following predictors were identified to significantly influence the closure rate: tractional hole index (THI), axial length, time between first and second surgery, and the experience of the surgeon (p < 0.05). Conclusions: Re-vitrectomy with APC led to the closure of 60.2% of the persistent MHs. The closure rate negatively correlates with increasing axial length, time between the first and second surgery, and the decreased THI. Further, experienced surgeons (with a history of >100 pars plana vitrectomies with ILM peeling) had significantly higher closure rates.
References
1.
Kelly
NE
, Wendel
RT
. Vitreous surgery for idiopathic macular holes. Results of a pilot study
. Arch Ophthalmol
. 1991
May
;109
(5
):654
–9
.
[PubMed]
0003-99502.
Yu
Y
, Liang
X
, Wang
Z
, Wang
J
, Liu
X
, Chen
J
, et al. Internal limiting membrane peeling and air tamponade for stage III and stage IV idiopathic macular hole
. Retina
. 2018
Oct
;1
.
[PubMed]
0275-004X3.
García-Layana
A
, García-Arumí
J
, Ruiz-Moreno
JM
, Arias-Barquet
L
, Cabrera-López
F
, Figueroa
MS
. A review of current management of vitreomacular traction and macular hole
. J Ophthalmol
. 2015
;2015
:809640
.
[PubMed]
2090-004X4.
Spiteri Cornish
K
, Lois
N
, Scott
N
, Burr
J
, Cook
J
, Boachie
C
, et al. Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH)
. Cochrane Database Syst Rev
. 2013
Jun
;(6
):CD009306
.
[PubMed]
1469-493X5.
Morescalchi
F
, Costagliola
C
, Gambicorti
E
, Duse
S
, Romano
MR
, Semeraro
F
. Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery
. Surv Ophthalmol
. 2017
Jan - Feb
;62
(1
):58
–69
.
[PubMed]
0039-62576.
Ip
MS
, Baker
BJ
, Duker
JS
, Reichel
E
, Baumal
CR
, Gangnon
R
, et al. Anatomical outcomes of surgery for idiopathic macular hole as determined by optical coherence tomography
. Arch Ophthalmol
. 2002
Jan
;120
(1
):29
–35
.
[PubMed]
0003-99507.
Ryan
EH
Jr, Gilbert
HD
. Results of surgical treatment of recent-onset full-thickness idiopathic macular holes
. Arch Ophthalmol
. 1994
Dec
;112
(12
):1545
–53
.
[PubMed]
0003-99508.
Wendel
RT
, Patel
AC
, Kelly
NE
, Salzano
TC
, Wells
JW
, Novack
GD
. Vitreous surgery for macular holes
. Ophthalmology
. 1993
Nov
;100
(11
):1671
–6
.
[PubMed]
0161-64209.
D’Souza
MJ
, Chaudhary
V
, Devenyi
R
, Kertes
PJ
, Lam
WC
. Re-operation of idiopathic full-thickness macular holes after initial surgery with internal limiting membrane peel
. Br J Ophthalmol
. 2011
Nov
;95
(11
):1564
–7
.
[PubMed]
0007-116110.
Moisseiev
E
, Fabian
ID
, Moisseiev
J
, Barak
A
. Outcomes of repeated pars plana vitrectomy for persistent macular holes
. Retina
. 2013
Jun
;33
(6
):1137
–43
.
[PubMed]
0275-004X11.
Che
X
, He
F
, Lu
L
, Zhu
D
, Xu
X
, Song
X
, et al. Evaluation of secondary surgery to enlarge the peeling of the internal limiting membrane following the failed surgery of idiopathic macular holes
. Exp Ther Med
. 2014
Mar
;7
(3
):742
–6
.
[PubMed]
1792-098112.
Hillenkamp
J
, Kraus
J
, Framme
C
, Jackson
TL
, Roider
J
, Gabel
VP
, et al. Retreatment of full-thickness macular hole: predictive value of optical coherence tomography
. Br J Ophthalmol
. 2007
Nov
;91
(11
):1445
–9
.
[PubMed]
0007-116113.
Valldeperas
X
, Wong
D
. Is it worth reoperating on macular holes?
Ophthalmology
. 2008
Jan
;115
(1
):158
–63
.
[PubMed]
0161-642014.
Ezra
E
, Aylward
WG
, Gregor
ZJ
. Membranectomy and autologous serum for the retreatment of full-thickness macular holes
. Arch Ophthalmol
. 1997
Oct
;115
(10
):1276
–80
.
[PubMed]
0003-995015.
Morizane
Y
, Shiraga
F
, Kimura
S
, Hosokawa
M
, Shiode
Y
, Kawata
T
, et al. Autologous transplantation of the internal limiting membrane for refractory macular holes
. Am J Ophthalmol
. 2014
Apr
;157
(4
):861
–869.e1
.
[PubMed]
0002-939416.
Pires
J
, Nadal
J
, Gomes
NL
. Internal limiting membrane translocation for refractory macular holes
. Br J Ophthalmol
. 2017
Mar
;101
(3
):377
–82
.
[PubMed]
1468-207917.
De Novelli
FJ
, Preti
RC
, Ribeiro Monteiro
ML
, Pelayes
DE
, Junqueira Nóbrega
M
, Takahashi
WY
. Autologous Internal Limiting Membrane Fragment Transplantation for Large, Chronic, and Refractory Macular Holes
. Ophthalmic Res
. 2015
;55
(1
):45
–52
.
[PubMed]
0030-374718.
Grewal
DS
, Mahmoud
TH
. Autologous Neurosensory Retinal Free Flap for Closure of Refractory Myopic Macular Holes
. JAMA Ophthalmol
. 2016
Feb
;134
(2
):229
–30
.
[PubMed]
2168-616519.
Grewal
DS
, Charles
S
, Parolini
B
, Kadonosono
K
, Mahmoud
TH
. Autologous Retinal Transplant for Refractory Macular Holes: Multicenter International Collaborative Study Group
. Ophthalmology
. 2019
Jan
;•••
:S0161-6420(18)32595-8
.
[PubMed]
0161-642020.
Reis
R
, Ferreira
N
, Meireles
A
. Management of Stage IV Macular Holes: When Standard Surgery Fails
. Case Rep Ophthalmol
. 2012
May
;3
(2
):240
–50
.
[PubMed]
1663-269921.
Chen
SN
, Yang
CM
. Lens capsular flap transplantation in the management of refractory macular hole from multiple etiologies
. Retina
. 2016
Jan
;36
(1
):163
–70
.
[PubMed]
0275-004X22.
Szigiato
AA
, Gilani
F
, Walsh
MK
, Mandelcorn
ED
, Muni
RH
. Induction of macular detachment for the treatment of persistent or recurrent idiopathic macular holes
. Retina
. 2016
Sep
;36
(9
):1694
–8
.
[PubMed]
0275-004X23.
Rao
X
, Wang
NK
, Chen
YP
, Hwang
YS
, Chuang
LH
, Liu
IC
, et al. Outcomes of outpatient fluid-gas exchange for open macular hole after vitrectomy
. Am J Ophthalmol
. 2013
Aug
;156
(2
):326
–333.e1
.
[PubMed]
0002-939424.
Cho
HY
, Kim
YT
, Kang
SW
. Laser photocoagulation as adjuvant therapy to surgery for large macular holes
. Korean J Ophthalmol
. 2006
Jun
;20
(2
):93
–8
.
[PubMed]
1011-894225.
Ohana
E
, Blumenkranz
MS
. Treatment of reopened macular hole after vitrectomy by laser and outpatient fluid-gas exchange
. Ophthalmology
. 1998
Aug
;105
(8
):1398
–403
.
[PubMed]
0161-642026.
Min
WK
, Lee
JH
, Ham
DI
. Macular hole surgery in conjunction with endolaser photocoagulation
. Am J Ophthalmol
. 1999
Mar
;127
(3
):306
–11
.
[PubMed]
0002-939427.
Ikuno
Y
, Kamei
M
, Saito
Y
, Ohji
M
, Tano
Y
. Photocoagulation and fluid-gas exchange to treat persistent macular holes after prior vitrectomy. A pilot study
. Ophthalmology
. 1998
Aug
;105
(8
):1411
–8
.
[PubMed]
0161-642028.
Lappas
A
, Foerster
AM
, Kirchhof
B
. Use of heavy silicone oil (Densiron-68) in the treatment of persistent macular holes
. Acta Ophthalmol
. 2009
Nov
;87
(8
):866
–70
.
[PubMed]
1755-375X29.
Cillino
S
, Cillino
G
, Ferraro
LL
, Casuccio
A
. Treatment of persistently open macular holes with heavy silicone oil (Densiron 68) versus C2F6. A prospective randomized study
. Retina
. 2016
Apr
;36
(4
):688
–94
.
[PubMed]
0275-004X30.
Rizzo
S
, Genovesi-Ebert
F
, Vento
A
, Cresti
F
, Miniaci
S
, Romagnoli
MC
. Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes: Densiron-68 endotamponade for persistent macular holes
. Graefes Arch Clin Exp Ophthalmol
. 2009
Nov
;247
(11
):1471
–6
.
[PubMed]
0721-832X31.
Faude
F
, Edel
E
, Dannhauer
M
, Petzel
C
, Meier
P
, Wiedemann
P
. Autologe Thrombozytenapplikation bei der Behandlung des idiopathischen Makulaforamens
. Ophthalmologe
. 1997
Dec
;94
(12
):877
–81
.
[PubMed]
0941-293X32.
Rizzo
S
, Caporossi
T
, Tartaro
R
, Finocchio
L
, Franco
F
, Barca
F
, Giansanti
F.
A Human Amniotic Membrane Plug to Promote Retinal Breaks Repair and Recurrent Macular Hole Closure.
Retina (Philadelphia, Pa) 2018
. 33.
Tam
AL
, Yan
P
, Gan
NY
, Lam
WC
. The current surgical management of large, recurrent, or persistent macular holes
. Retina
. 2018
Jul
;38
(7
):1263
–75
.
[PubMed]
0275-004X34.
Ruiz-Moreno
JM
, Staicu
C
, Piñero
DP
, Montero
J
, Lugo
F
, Amat
P
. Optical coherence tomography predictive factors for macular hole surgery outcome
. Br J Ophthalmol
. 2008
May
;92
(5
):640
–4
.
[PubMed]
0007-116135.
Dimopoulos
S
, William
A
, Voykov
B
, Ziemssen
F
, Bartz-Schmidt
KU
, Spitzer
MS
. Anatomical and visual outcomes of autologous thrombocyte serum concentrate in the treatment of persistent full-thickness idiopathic macular hole after ILM peeling with brilliant blue G and membrane blue dual
. Acta Ophthalmol
. 2017
Aug
;95
(5
):e429
–30
.
[PubMed]
1755-375X36.
Purtskhvanidze
K
, Frühsorger
B
, Bartsch
S
, Hedderich
J
, Roider
J
, Treumer
F
. Persistent Full-Thickness Idiopathic Macular Hole: Anatomical and Functional Outcome of Revitrectomy with Autologous Platelet Concentrate or Autologous Whole Blood
. Ophthalmologica
. 2018
;239
(1
):19
–26
.
[PubMed]
0030-375537.
Duker
JS
, Kaiser
PK
, Binder
S
, de Smet
MD
, Gaudric
A
, Reichel
E
, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole
. Ophthalmology
. 2013
Dec
;120
(12
):2611
–9
.
[PubMed]
0161-642038.
Kusuhara
S
, Teraoka Escaño
MF
, Fujii
S
, Nakanishi
Y
, Tamura
Y
, Nagai
A
, et al. Prediction of postoperative visual outcome based on hole configuration by optical coherence tomography in eyes with idiopathic macular holes
. Am J Ophthalmol
. 2004
Nov
;138
(5
):709
–16
.
[PubMed]
0002-9394© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
